Effect of curcumin-piperine in patients with ischemic stroke

Not Applicable

Conditions: Ischemic stroke.
Cerebral infarction

Registration Number: IRCT20121216011763N48

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 80

Inclusion Criteria

The person has had a stroke only once
At least 3-6 months have passed since the stroke (subacute and chronic phase)
NIHSS =5-24
diagnosis of stroke by CT-scan and MRI
Age=20-65 years old
BMI=18/5-35
Tendency to participate in the study

Exclusion Criteria

Taking anticoagulants such as aspirin, heparin, warfarin, etc.
Taking antioxidant and multivitamin supplements and omega-3 supplements
Having malignant diseases and cancers

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HS-CRP. Timepoint: The beginning and the end of the study. Method of measurement: ELISA kit.;TAC. Timepoint: The beginning and the end of the study. Method of measurement: Laboratory method.;Fibrinogen plasma level. Timepoint: The beginning and the end of the study. Method of measurement: ELISA kit.;Lipid profile. Timepoint: The beginning and the end of the study. Method of measurement: Enzymatic method.;Systolic and diastolic blood pressure. Timepoint: The beginning and the end of the study. Method of measurement: Mercury Barometer.

Secondary Outcome Measures

Name	Time	Method
Weight. Timepoint: The beginning and the end of the study. Method of measurement: Digital scale.;Waist Circumference (WC). Timepoint: The beginning and the end of the study. Method of measurement: Inelastic meters.;Body mass index (BMI). Timepoint: The beginning and the end of the study. Method of measurement: Dividing the weight into kilograms by squared height by meter.